These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27015127)

  • 1. Sequential Serum Metabolomic Profiling after Radiofrequency Ablation of Hepatocellular Carcinoma Reveals Different Response Patterns According to Etiology.
    Goossens C; Nahon P; Le Moyec L; Triba MN; Bouchemal N; Amathieu R; Ganne-Carrié N; Ziol M; Trinchet JC; Sellier N; Diallo A; Seror O; Savarin P
    J Proteome Res; 2016 May; 15(5):1446-54. PubMed ID: 27015127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
    Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
    Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
    Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
    Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial.
    Liao M; Zhong X; Zhang J; Liu Y; Zhu Z; Wu H; Zeng Y; Huang J
    J Surg Oncol; 2017 Jun; 115(8):971-979. PubMed ID: 28334430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma.
    Canale M; Ulivi P; Foschi FG; Scarpi E; De Matteis S; Donati G; Ercolani G; Scartozzi M; Faloppi L; Passardi A; Tamburini E; Valgiusti M; Marisi G; Frassineti GL; Casadei Gardini A
    Crit Rev Oncol Hematol; 2018 Sep; 129():44-53. PubMed ID: 30097237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
    Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
    J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices.
    Zhang K; Jiang L; Jia Z; Zhang Y; He R; Ding Z; Mu Y
    Dig Dis Sci; 2015 May; 60(5):1490-501. PubMed ID: 25431044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma.
    Machi J; Bueno RS; Wong LL
    World J Surg; 2005 Nov; 29(11):1364-73. PubMed ID: 16240062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers.
    Ueno M; Hayami S; Shigekawa Y; Kawai M; Hirono S; Okada K; Tamai H; Shingaki N; Mori Y; Ichinose M; Yamaue H
    J Hepatol; 2015 Dec; 63(6):1352-9. PubMed ID: 26212030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis C virus-related hepatocellular carcinoma after radiofrequency thermal ablation.
    Nishikawa H; Osaki Y; Iguchi E; Koshikawa Y; Ako S; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Sakamoto A; Henmi S; Hatamaru K; Ishikawa T; Saito S; Nasu A; Kita R; Kimura T
    J Clin Gastroenterol; 2013 Apr; 47(4):359-66. PubMed ID: 23090049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment.
    Hu XY; Li L; Wu HT; Liu Y; Wang BD; Tang Y
    Pathol Res Pract; 2018 Oct; 214(10):1655-1660. PubMed ID: 30153957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis.
    Nahon P; Amathieu R; Triba MN; Bouchemal N; Nault JC; Ziol M; Seror O; Dhonneur G; Trinchet JC; Beaugrand M; Le Moyec L
    Clin Cancer Res; 2012 Dec; 18(24):6714-22. PubMed ID: 23136190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
    Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Chung HA; Kim JH; Hwang Y; Choi HS; Ko SY; Choe WH; Kwon SY
    Saudi J Gastroenterol; 2016; 22(1):57-63. PubMed ID: 26831608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.